Recommended Topic Related To:

Ethamolin

"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.

Dotarem is a gadolinium-based"...

Ethamolin

Ethamolin Patient Information including How Should I Take

What should I discuss with my health care provider before receiving ethanolamine oleate (Ethamolin)?

You should not use this medication if you are allergic to ethanolamine oleate or oleic acid (oleo).

Ethanolamine oleate will not treat any underlying liver disease.

If possible before you receive ethanolamine oleate, tell your doctor if you have:

  • kidney disease;
  • heart disease; or
  • lung disease.

FDA pregnancy category C. It is not known whether ethanolamine oleate will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

It is not known whether ethanolamine oleate passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

In an emergency situation it may not be possible before you are treated with ethanolamine oleate to tell your caregivers if you are pregnant or breast feeding. Make sure any doctor caring for your pregnancy or your baby knows you have received this medication.

How is ethanolamine oleate given (Ethamolin)?

Ethanolamine oleate is injected directly into the vein. You will receive this injection in a hospital or emergency setting.

This medication is usually given during a bleeding episode and again at 1 week, 6 weeks, 3 months, and 6 months afterward.

Do not miss any follow-up visits to your doctor.

Side Effects Centers
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.